Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-05 @ 8:19 PM
Study NCT ID:
NCT01080027
Status:
COMPLETED
Last Update Posted:
2014-07-31
First Post:
2010-03-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-02
First Submit QC Date:
None
Study First Post Date:
2010-03-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-30
Last Update Post Date:
2014-07-31
Last Update Post Date Type:
ESTIMATED